[Neuromuscular effects of hexafluorene bromide in association with succinylcholine].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D004357:Drug Synergism; D005260:Female; D005449:Fluorenes / Q000494:pharmacology*; D006584:Hexamethonium Compounds / Q000494:pharmacology*; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009469:Neuromuscular Junction / Q000502:physiology*; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology*; D013390:Succinylcholine / Q000494:pharmacology*
D002800:Cholinesterase Inhibitors; D004338:Drug Combinations; D005449:Fluorenes; D006584:Hexamethonium Compounds; D003473:Neuromuscular Nondepolarizing Agents; D013390:Succinylcholine
Effectos neuromusculares de la asociación bromuro de hexafluorenio-succinilcolina.